NCT05671588

Brief Summary

This study is focused on patients with multiple sclerosis (MS), their cardiovascular fitness, and the effect of combined controlled training on the perception of fatigue, the development of depression, and quality of life in the first year after diagnosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started May 2022

Longer than P75 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2022

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 4, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

January 16, 2024

Status Verified

January 1, 2024

Enrollment Period

3.2 years

First QC Date

December 12, 2022

Last Update Submit

January 12, 2024

Conditions

Keywords

Multiple SclerosisControlled combined exerciseCardiovascular fitnessFatigueDepression

Outcome Measures

Primary Outcomes (2)

  • Maximal aerobic capacity (VO2max.kg-1)

    Change after six months follow up in conventional, experimental and control group

    6 months

  • Power to weight ratio (W.kg-1)

    Change after six months follow up in conventional, experimental and control group

    6 months

Secondary Outcomes (7)

  • Modified Fatigue Impact Scale (MFIS)

    6 months

  • Symptom-Checklist-90-Standard (SCL-90-S)

    6 months

  • Beck Depression Inventory Score II (BDI II)

    6 months

  • 36-Item Short Form Survey (SF-36)

    6 months

  • Maximal heart rate (bpm)

    6 months

  • +2 more secondary outcomes

Other Outcomes (1)

  • Cost-benefit analysis of early rehabilitation intervention (CZK)

    6 months

Study Arms (3)

Controlled combined program (aerobic-resistant)

EXPERIMENTAL

Patients randomized into the Experimental arm will undergo controlled exercise on a cycling ergometer in combination with strength training on a multifunctional fitness device for 1-hour duration, twice a week for one month, and once a week for the next month (12 therapies in total).

Procedure: Controlled combined exercise group

Conventional rehabilitation

ACTIVE COMPARATOR

Patients randomized into this study arm will undergo conventional rehabilitation.

Procedure: Conventional rehabilitation

No intervention

NO INTERVENTION

Patients randomized into this study arm will undergo no intervention and will serve as the control group.

Interventions

Patients will undergo protocol-defined combined aerobic-resistant therapy on a cycling ergometer and multifunctional fitness device

Controlled combined program (aerobic-resistant)

Patients will undergo conventional rehabilitation.

Conventional rehabilitation

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 20 - 45 years
  • Newly diagnosed patients with multiple sclerosis
  • Relapsing-remitting MS (RRMS) or clinically isolated syndrome (CIS)
  • EDSS 0-6
  • Signed informed consent

You may not qualify if:

  • Progressive forms of MS (PRMS or SPMS), Malignant MS
  • Non-cooperation, disagreement with the study
  • Contraindication to spiroergometry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, 708 52, Czechia

RECRUITING

Related Publications (4)

  • Razazian N, Kazeminia M, Moayedi H, Daneshkhah A, Shohaimi S, Mohammadi M, Jalali R, Salari N. The impact of physical exercise on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurol. 2020 Mar 13;20(1):93. doi: 10.1186/s12883-020-01654-y.

    PMID: 32169035BACKGROUND
  • Taul-Madsen L, Connolly L, Dennett R, Freeman J, Dalgas U, Hvid LG. Is Aerobic or Resistance Training the Most Effective Exercise Modality for Improving Lower Extremity Physical Function and Perceived Fatigue in People With Multiple Sclerosis? A Systematic Review and Meta-analysis. Arch Phys Med Rehabil. 2021 Oct;102(10):2032-2048. doi: 10.1016/j.apmr.2021.03.026. Epub 2021 Apr 24.

    PMID: 33901439BACKGROUND
  • Cruickshank TM, Reyes AR, Ziman MR. A systematic review and meta-analysis of strength training in individuals with multiple sclerosis or Parkinson disease. Medicine (Baltimore). 2015 Jan;94(4):e411. doi: 10.1097/MD.0000000000000411.

    PMID: 25634170BACKGROUND
  • Hansen D, Wens I, Keytsman C, Eijnde BO, Dendale P. Is long-term exercise intervention effective to improve cardiac autonomic control during exercise in subjects with multiple sclerosis? A randomized controlled trial. Eur J Phys Rehabil Med. 2015 Apr;51(2):223-31. Epub 2014 Mar 6.

    PMID: 24603938BACKGROUND

MeSH Terms

Conditions

Multiple SclerosisFatigueDepression

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Study Officials

  • Anna Šilarová, MD

    University Hospital Ostrava

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jiří Hynčica

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
All participants of the study will undergo a clinical examination including a questionnaire survey and spiroergometry - examiners will not have access to intervention documents before and after the intervention (period of 6 months), as well as examiners will not perform the therapy.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The study subjects will be enrolled into two parallel groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2022

First Posted

January 4, 2023

Study Start

May 1, 2022

Primary Completion

June 30, 2025

Study Completion

December 31, 2025

Last Updated

January 16, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data available to other researchers. The data may be provided upon request.

Locations